'Amazing recognition' for charity set up in memory of inspirational baby Evie
This is a charity based in West Cumbria set up in memory of Greg's daughter Evie, who died in 2015. Throughout Evie's life he kept updating everyone on her progress and difficulties through Facebook.
He said: 'It became apparent that Evie had quite a following of well-wishers and based on the greeting one particular consultant gave us on the ward each morning Team Evie was born! So many people sent love, support and hope Evie's way during her life and she inspired so many people.
'Evie's influence and inspiration spread far and wide, reaching places all over the world. When Evie passed away it became clear that as a community, Team Evie needed to continue her positive impact on the world and the charity was created! We aim to spread Evie's story, love and inspiration as far and wide as we can by helping as many children and their families as possible.
'Our work is saving children's lives and helping sick children and their families across our region.
'Over the last 10 years we have worked tirelessly to develop projects and donations which make a real impact for sick children and their families.
'We support families from the moment a child is taken ill or injured and throughout their journey. We know our work is making time in hospital easier for children and their families, reducing anxiety and saving children's lives.'
Team Evie were absolute delighted to receive the award in the year that marks a decade of the charity.
Speaking after the win, Greg said: 'Its amazing for Evie to have the win, because obviously as her parents and us wanting to do everything for her.
'To have it recognised the impact that she has had on so many families lives its been amazing.'
Jill added that the award highlights how inspirational over the years.
She said: 'Considering we are such a small charity, its amazing recognition.'
The pair highlighted how evening like the Pride of Cumbria 'allow you to stop and reflect' on the achievements of the charity.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
25 minutes ago
- CBS News
8 babies born with DNA from 3 people in world-first IVF trial aimed at minimizing risk of inherited disease
Eight healthy babies have been born in the U.K. using a new IVF technique that successfully reduced their risk of inheriting genetic diseases from their mothers, the people behind a world-first trial said Wednesday. The findings were hailed as a breakthrough, which raises hopes that women with mutations in their mitochondrial DNA could one day have children without passing debilitating or deadly diseases on to the children. One out of every 5,000 births is affected by mitochondrial diseases, which cannot be treated, and include symptoms such as impaired vision, diabetes and muscle wasting. In 2015, Britain became the first country to approve an in-vitro fertilization technique that uses a small amount of healthy mitochondrial DNA from the egg of a donor — along with the mother's egg and father's sperm. Some have called the result of this process "three-parent babies," though researchers have pushed back at this term because only roughly 0.1% of the newborn's DNA comes from the donor. The results of the much-awaited U.K. trial were published in several papers in the New England Journal of Medicine. Out of 22 women to undergo the treatment at the Newcastle Fertility Centre in northeast England, eight babies were born. The four boys and four girls now range from under 6 months to over 2 years old. The amount of mutated mitochondrial DNA — which causes disease — was reduced by 95-100% in six of the babies, according to the research. For the other two newborns, the amount fell by 77-88%, which is still below the range that causes disease. This indicates the technique was "effective in reducing transmission" of diseases between mother and child, one of the studies said. The eight children are currently healthy, though one had a disturbance of their heart's rhythm which was successfully treated, the researchers said. Their health will be followed up over the coming years to see if problems arise. Oxford University reproductive genetics expert Dagan Wells noted that among the eight children, three have shown some signs of what is known as "reversal," which is still little understood. It is "a phenomenon where the therapy initially succeeds in producing an embryo with very few defective mitochondria, but by the time the child is born the proportion of abnormal mitochondria in its cells has significantly increased," he explained. Nevertheless, Nils-Goran Larsson, a Swedish reproductive expert not involved in the research, hailed it as a "breakthrough." The new technique offers a "very important reproductive option" for families affected by "devastating" mitochondrial diseases, he added. While the U.K. trial is the first to involve multiple mothers, the eight babies born to them are not the first to be born with DNA from three people. That first came in 2016, after a woman was treated by U.S. fertility specialists in Mexico, where there were no laws regulating the practice. A similar IVF method was used in that groundbreaking case. Mitochondrial donation remains controversial and has not been approved in many countries, including the United States and France. Religious leaders have opposed the procedure because it involves the destruction of human embryos. Other opponents have expressed fears it could pave the way for genetically engineered "designer babies." An ethical review carried out by the U.K.'s independent Nuffield Council on Bioethics was "instrumental" in conducting the new research, the council's director Danielle Hamm said Wednesday. Peter Thompson, head of the U.K.'s Human Fertilisation and Embryology Authority, which approved the procedure, said only people with a "very high risk" of passing on a mitochondrial disease would be eligible for the treatment. Ethical concerns have also been raised over the use of mitochondrial donation for infertility in Greece and Ukraine. French mitochondrial disease specialist Julie Steffann told AFP that "it is a question of the risk-benefit ratio: for a mitochondrial disease, the benefit is obvious." "In the context of infertility, it has not been proven," she added.
Yahoo
an hour ago
- Yahoo
Scientists unlock secret behind rare disease where flu can cause paralysis
The family of a man who was paralysed at the age of two after catching the flu have expressed their 'hope' as scientists have discovered that a faulty gene may be responsible for the rare condition. It is hoped that the finding could potentially one day lead to a treatment for the illness. When Timothy Bingham was two, he had a mild flu-like illness which left him unable to walk. Three years later following another infection, he was paralysed and has been in a wheelchair ever since. Kate Bingham, mother of Timothy, who is now 28, said: 'About 25 years ago Tim got a flu like infection and a temperature. 'What seemed like a minor illness had devastating consequences. 'The attack, and subsequent attacks – did terrible damage. First to his legs, then his arms, his face and his chest. 'And now he needs 24-hour care. His diaphragm barely works at all so he can't cough. 'It's hard for him to chew and he can't drink unassisted. He can't move in bed so needs turning throughout the night. The things we all take for granted he can't do.' The rare condition was spotted again in 2011 when an unnamed eight-month-old girl was left unable to breathe on her own without the support of a ventilator after a mild chest infection. Scientists suspected that there could be a genetic reason behind the condition after the girl's two brothers had experienced similar severe problems following mild infections. Now scientists at the University of Manchester have found a genetic mechanism behind the severe reactions to mild infections seen among these children – a change to a gene called RCC1. Researchers found that 24 children from 12 families from the UK, Turkey, the Czech Republic, Germany, Iran, India, Saudi Arabia, Cyprus, and Slovakia have been found to have changes in the same gene. Writing in the journal Lancet Neurology, the research team describe how the condition 'mimics' Guillain-Barre syndrome – a rare condition in which a person's immune system attacks the nerves – and 'overlaps mechanistically' with motor neurone disease. The research team, led by Professor Bill Newman from the University of Manchester, said that their study reveals that 'variants in RCC1 as a novel cause of neurological disease.' 'Until this study, little was known about why some people experience severe nerve damage after they have had a mild infection like flu or a stomach upset,' Professor Newman said. 'This work provides families with an explanation and is the first step in us developing an effective treatment. As children are well before they develop nerve damage following an infection, this gives us an opportunity to treat at risk children before problems occur. 'The similarity with Guillain-Barre syndrome and with conditions like motor neuron disease may help us understand these more common conditions and why some people are at greater risk and what treatments may be effective.' Mrs Bingham from Cheltenham, Gloucestershire, said: 'As Tim's mum the discovery of a gene which is linked to what happened to Tim means everything to me. 'For so long we have lived with uncertainty of not knowing the full picture. 'This breakthrough brings us great hope as it will do to all those people who have waited years for answers. This is something that helps us look to the future.' She added: 'I'm proud of how strong Tim has been. 'He now has a girlfriend he met online who is wonderful. 'He proves there is life beyond disability.' The study was funded by the National Institute for Health and Care Research, LifeArc and the Wellcome Trust. Sam Barrell, chief executive of LifeArc, said, 'For many people living with rare conditions, the wait for a diagnosis can be agonisingly long – around a third wait more than five years. 'In Timothy's case, that uncertainty stretched for over twenty years. 'This discovery provides a potential target for treatment and the first step towards delivering a brighter future for people that could be living with this same devastating condition.'
Yahoo
an hour ago
- Yahoo
UK watchdog bans Trip drinks ad over health, nutrition claims
An advert from UK CBD drinks brand Trip has been banned by the local advertising watchdog over several health and nutrition claims. Last December, Trip promoted a product that did not contain CBD in an online ad. The cucumber and mint beverage came from the company's Mindful Blend range, includes a blend of magnesium, Lion's Mane and other ingredients. Among the claims in the advert was that the drink could "help you feel calm'. The Advertising Standards Authority (ASA) upheld three complaints linked to the advert. The complaints centred on claims the drink reduced stress, promoted feelings of calm and whether a '0g added sugar' nutrition claim breached UK ad rules. The ASA said the advert "implied the magnesium in the product could reduce serum cortisol levels" and included phrases that indicated the product would help consumers relax. It also ruled the claims around the anxiety and stress reducing aspects of Lion's Mane "were claims that a food could prevent, treat or cure disease", which is prohibited by the watchdog's CAP code. "We considered those claims were specific health claims for the purposes of the code, because they implied that the ingredients had beneficial health effects," the ASA said. "However, we had not seen any evidence which demonstrated that those claims were authorised on the GB Register and they therefore breached the Code." Under the code, health claims can only be used in marketing of food and food supplements if they have been authoritised on the GB register. Commenting on the ruling, Rachael Matthews, product director at Trip, said: "All statements regarding the relevant product's calming properties were based on real world studies conducted with human participants. "We will update our advertising and continue to work closely with regulators to ensure that Trip can continue to educate consumers about the functionality of ingredients in its drinks whilst complying with all applicable regulatory requirements.' The third complaint upheld by the ASA was around a claim in the advert that the drink contained "0g added sugar". According to the ASA, such a claim indicates a product is "with no added sugars", though the use of the claim, it said, was allowed "only where a product did not contain any added omo- or disaccharides, or any other food used for its sweetening properties". Given the product contained erythritol and stevia sweeteners, and naturally occuring sugars from fruit concentrate, the ASA ruled the "0g added sugar" claim "did not comply with the conditions of use associated with the equivalent 'with no added sugars' nutrition claim and therefore breached the code". Matthews added: "All sugar used in Trip drinks is naturally occurring from fruit juice. As recognised in the Advertising Standards Authority's ruling, such fruit juice is used for its contribution to a number of different functional aspects of the drinks. "In accordance with the ruling, Trip is taking steps to change its advertising of the relevant product to make this clearer to consumers." "UK watchdog bans Trip drinks ad over health, nutrition claims" was originally created and published by Just Drinks, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
